gonorrhoeae vaccine NgG, which is in phase 2 development and was awarded fast-track status from the FDA last year. There are real concerns that we could be entering a post-antibiotic era ...

The coveted status is for GSK’s NgG vaccine candidate, currently in a phase 2 trial in adults aged 18 to 50 considered to be at risk from infection with Neisseria gonorrhoeae, the bacteria that ...

AMR: Antimicrobial resistance; ESC: Extended-spectrum cephalosporin; MDR-NG: Multidrug-resistant Neisseria gonorrhoeae. Box 3. Areas of attention of a WHO Working Group on multidrug-resistant and ...

The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

Explore how evolving tools and emerging pathogens are reshaping the diagnosis and treatment of Pelvic Inflammatory Disease.

Antimicrobial resistance is the ability of microorganisms such as bacteria, fungi or protozoans to grow despite exposure to antimicrobial substances designed to inhibit their growth. Microbes can ...

In basic terms, vaginal infections tend to develop when something affects the usual balance of bacteria and yeast in your vagina. Here are the common causes of vaginal infections by infection type ...